We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
METC icon
2576
Ramaco Resources Class A
METC
$692M
$104K ﹤0.01%
12,268
LOCO icon
2577
El Pollo Loco
LOCO
$463M
$104K ﹤0.01%
+10,464
New +$109K
MGTX icon
2578
MeiraGTx Holdings
MGTX
$1.2B
$104K ﹤0.01%
15,970
HUN icon
2579
Huntsman Corp
HUN
$1.78B
$104K ﹤0.01%
3,767
-164
-4% -$4.46K
GFS icon
2580
GlobalFoundries
GFS
$29.2B
$103K ﹤0.01%
1,920
-19
-1% -$1.11K
GBIO
2581
DELISTED
Generation Bio
GBIO
$103K ﹤0.01%
2,632
FRPT icon
2582
Freshpet
FRPT
$3.48B
$103K ﹤0.01%
1,949
-39
-2% -$2.32K
IE icon
2583
Ivanhoe Electric
IE
$1.7B
$103K ﹤0.01%
+8,464
New +$88.7K
ABUS icon
2584
Arbutus Biopharma
ABUS
$908M
$103K ﹤0.01%
44,135
-14,321
-24% -$34.3K
NKTX icon
2585
Nkarta
NKTX
$171M
$103K ﹤0.01%
17,113
UNTY icon
2586
Unity Bancorp
UNTY
$619M
$102K ﹤0.01%
+3,743
New +$103K
ITIC
2587
Investors Title Co
ITIC
$530M
$102K ﹤0.01%
+690
New +$100K
EGAN icon
2588
eGain
EGAN
$200M
$102K ﹤0.01%
+11,241
New +$92.5K
CDLX icon
2589
Cardlytics
CDLX
$24.7M
$101K ﹤0.01%
1,748
ICVX
2590
DELISTED
Icosavax, Inc. Common Stock
ICVX
$101K ﹤0.01%
+12,698
New +$54.5K
LOGC
2591
DELISTED
ContextLogic
LOGC
$100K ﹤0.01%
6,862
-3,289
-32% -$67.6K
QUOT
2592
DELISTED
Quotient Technology Inc
QUOT
$100K ﹤0.01%
29,187
-19,525
-40% -$55.2K
KPTI icon
2593
Karyopharm Therapeutics
KPTI
$46M
$99.9K ﹤0.01%
1,960
-801
-29% -$55.5K
TDAY
2594
USA Today Co
TDAY
$1.01B
$99.9K ﹤0.01%
49,226
-27,933
-36% -$53.6K
ADV icon
2595
Advantage Solutions
ADV
$399M
$98.8K ﹤0.01%
1,900
NGMS
2596
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$98.6K ﹤0.01%
8,090
FREE
2597
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$98.6K ﹤0.01%
+24,219
New +$88K
BLBD icon
2598
Blue Bird Corp
BLBD
$2.04B
$98.6K ﹤0.01%
+9,202
New +$92.4K
WHWK
2599
Whitehawk Therapeutics
WHWK
$269M
$98.4K ﹤0.01%
+7,671
New +$100K
EVA
2600
DELISTED
Enviva Inc.
EVA
$98K ﹤0.01%
1,850
-48
-3% -$2.74K

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.